Get the Stockscreener App
2.75
0.36%
0.010
After Hours:
2.75
Orchestra Biomed Holdings Inc stock is traded at $2.75, with a volume of 209.68K.
It is up +0.36% in the last 24 hours and up +3.00% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$2.74
Open:
$2.76
24h Volume:
209.68K
Relative Volume:
0.63
Market Cap:
$148.38M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-1.8333
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
+0.73%
1M Performance:
+3.00%
6M Performance:
-36.19%
1Y Performance:
-52.50%
1-Day Range:
$2.66
$2.78
1-Week Range:
$2.65
$2.78
52-Week Range:
$2.37
$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.75 | 147.84M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Will Orchestra BioMed Holdings Inc. Recover After Recent Decline2025 Analyst Calls & AI Powered Market Trend Analysis - beatles.ru
What technical models suggest about Orchestra BioMed Holdings Inc.’s comeback2025 Trading Recap & Reliable Volume Spike Trade Alerts - Newser
Is it time to cut losses on Orchestra BioMed Holdings Inc.Earnings Trend Report & Capital Efficient Trade Techniques - Newser
Historical volatility pattern of Orchestra BioMed Holdings Inc. visualized2025 Macro Impact & AI Driven Stock Movement Reports - Newser
Detecting price anomalies in Orchestra BioMed Holdings Inc. with AIQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Analyzing net buyer seller activity in Orchestra BioMed Holdings Inc.Bull Run & Daily Stock Momentum Reports - Newser
What is Orchestra BioMed Holdings Inc. s P E ratio telling usMarket Risk Report & Daily Oversold Stock Bounce Ideas - خودرو بانک
Technical signs of recovery in Orchestra BioMed Holdings Inc.Weekly Volume Report & Entry Point Confirmation Signals - Newser
Real time scanner hits for Orchestra BioMed Holdings Inc. explainedWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Understanding Orchestra BioMed Holdings Inc.’s price movementInsider Buying & Reliable Momentum Entry Alerts - Newser
Is a relief rally coming for Orchestra BioMed Holdings Inc. holdersDividend Hike & Free High Return Stock Watch Alerts - Newser
Is Orchestra BioMed Holdings Inc.’s ROE strong enoughWeekly Profit Analysis & Weekly Stock Breakout Alerts - خودرو بانک
How much upside does Orchestra BioMed Holdings Inc. haveJuly 2025 Trends & Expert Approved Trade Ideas - خودرو بانک
Medtronic (MDT) Collaborates with Orchestra BioMed on Promising AVIM Therapy - GuruFocus
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - Investing News Network
Orchestra BioMed Presents New AVIM Therapy Clinical Data at - GlobeNewswire
8.9mmHg Blood Pressure Drop Sustained for 3.6 Years: Orchestra BioMed's AVIM Therapy Shows Promise for Millions - Stock Titan
Orchestra BioMed stock price target lowered to $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Orchestra BioMed stock price target lowered to $10 at H.C. Wainwright - Investing.com Australia
Technical signs of recovery in Orchestra BioMed Holdings Inc2025 Analyst Calls & AI Driven Stock Reports - Newser
Published on: 2025-09-04 04:14:44 - Newser
Can volume confirm reversal in Orchestra BioMed Holdings Inc.Portfolio Value Report & AI Powered Buy/Sell Recommendations - Newser
Using data tools to time your Orchestra BioMed Holdings Inc. exitQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Will Orchestra BioMed Holdings Inc. bounce back from current supportMarket Movement Recap & AI Based Buy and Sell Signals - Newser
Can you recover from losses in Orchestra BioMed Holdings Inc.Quarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Comparing Orchestra BioMed Holdings Inc. in custom built stock radarsWeekly Trade Summary & Growth-Oriented Investment Plans - Newser
Orchestra Biomed Collects New Proceeds for Hypertension Study Enrollment - Medical Product Outsourcing
Can Orchestra BioMed Holdings Inc. be the next market leaderTrade Analysis Report & AI Driven Price Predictions - khodrobank.com
Analyzing Orchestra BioMed Holdings Inc. with risk reward ratio chartsWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
How cyclical is Orchestra BioMed Holdings Inc.’s revenue streamJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - خودرو بانک
Published on: 2025-09-03 05:17:06 - Newser
Is Orchestra BioMed Holdings Inc. stock forming a triangle pattern2025 Sector Review & Weekly Setup with ROI Potential - خودرو بانک
Published on: 2025-09-03 08:30:17 - خودرو بانک
Chart overlay techniques for tracking Orchestra BioMed Holdings Inc.July 2025 Summary & Stock Timing and Entry Methods - Newser
Is Orchestra BioMed Holdings Inc. stock a smart retirement pick2025 Macro Impact & Weekly Chart Analysis and Trade Guides - خودرو بانک
How sensitive is Orchestra BioMed Holdings Inc. to inflationMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Orchestra BioMed : Corporate Presentation Q3 2025 - MarketScreener
Published on: 2025-09-02 10:10:52 - Newser
Can Orchestra BioMed Holdings Inc. ride the EV waveJuly 2025 Action & Entry Point Confirmation Alerts - khodrobank.com
Analyzing drawdowns of Orchestra BioMed Holdings Inc. with statistical toolsJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Will Orchestra BioMed Holdings Inc. rebound enough to break evenMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Is Orchestra BioMed Holdings Inc. a candidate for recovery playPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Candlestick signals on Orchestra BioMed Holdings Inc. stock todayWeekly Market Report & Risk Controlled Swing Alerts - Newser
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):